Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11180494 Substituted amino acids as integrin inhibitors

Patent 11180494 was granted and assigned to Pliant Therapeutics on November, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Pliant Therapeutics

Current Assignee

Pliant Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11180494

Date of Patent

November 23, 2021

Patent Application Number

16596649

Date Filed

October 8, 2019

Patent Citations Received

‌

US Patent 12018025 Integrin inhibitor and uses thereof

‌

US Patent 11560376 Amino acid compounds and methods of use

‌

US Patent 11634418 Amino acid compounds and methods of use

‌

US Patent 11673887 N-acyl amino acid compounds and methods of use

‌

US Patent 11396506 Amino acid compounds with unbranched linkers and methods of use

‌

US Patent 11419869 Dosage forms and regimens for amino acid compounds

‌

US Patent 11858931 Amino acid compounds with unbranched linkers and methods of use

‌

US Patent 11952376 Substituted amino acids as integrin inhibitors

Patent Primary Examiner

‌

Douglas M Willis

Patent abstract

The invention relates to compounds of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11180494 Substituted amino acids as integrin inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API